Rhinomed Limited
Rhinomed Limited (RHNMF) Stock Overview
Explore Rhinomed Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
5.4M
P/E Ratio
-0.70
EPS (TTM)
$-0.02
ROE
15.91%
RHNMF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Rhinomed Limited (RHNMF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.70 and a market capitalization of 5.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.